Top compounds associated with response to USP17L29


Feature Type Standardized
Nominal ANOVA
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.064 0.2
mRNA PF-184 CTRPv2 pan-cancer AAC 0.042 0.2
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.041 0.2
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.038 0.2
mRNA barasertib CTRPv2 pan-cancer AAC 0.039 0.2
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA tamatinib CTRPv2 pan-cancer AAC 0.045 0.2
mRNA MI-1 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.044 0.2
Download CSV